cytarabine and pk 11195

cytarabine has been researched along with pk 11195 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appelbaum, FR; Banker, DE; Cooper, JJ; Cotter, FE; Fennell, DA; Willman, CL	1

Other Studies

1 other study(ies) available for cytarabine and pk 11195

Article	Year
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leukemia research, 2002, Volume: 26, Issue:1 Topics: Acute Disease; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Resistance, Multiple; Flow Cytometry; Humans; Isoquinolines; Leukemia, Myeloid; Ligands; Receptors, GABA-A; Tumor Cells, Cultured	2002

Article

Year

PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.

Leukemia research, 2002, Volume: 26, Issue:1

Topics: Acute Disease; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Resistance, Multiple; Flow Cytometry; Humans; Isoquinolines; Leukemia, Myeloid; Ligands; Receptors, GABA-A; Tumor Cells, Cultured

2002